about us

Follow Us

Home News Treatment Cases Consultation Ask Us About us FAQ Quick Contact

Our Vision: Cancer is painful but the treatments shouldn’t be. For advanced-stage cancer patients, the cutting-edge therapies available in China offer a better hope for a prolonged life. The benefits of our biomedical method include a higher rate of cancer survivorship, a lower percentage of cancer recurrence and metastasis, minimal pain, minimal side effects, and a higher quality of life. Cancer can be treated by surgery, chemotherapy, radiation therapy, immunotherapy, monoclonal antibody therapy or other methods. The choice of therapy depends upon the location and grade of the tumor and the stage of the disease, as well as the general state of the patient (performance status). A number of experimental cancer treatments are also under development. Complete removal of the cancer without damage to the rest of the body is the goal of treatment. Sometimes this can be accomplished by surgery, but the propensity of cancers to invade adjacent tissue or to spread to distant sites by microscopic metastasis often limits its effectiveness. The effectiveness of chemotherapy is often limited by toxicity to other tissues in the body. Radiation can also cause damage to normal tissue. Many of our treatments are not fully available in other developed countries, offering China a unique leading advantage. We work with hospitals that provide a systematic combination of the following treatments to combat cancer Our Mission: The Cancer Bio Master offers a unique concept in the diagnosis and biotreatment of cancer in Beijing according to the international standard of oncological care. Our goal is to provide the most up-to-date treatments to maximize the chance for cure and effective long-term control of oncological disorders. We also provide services for consultation, screening and early detection of cancer. We have a multidisciplinary team of physicians, nurses and supporting personnel, who are committed to provide compassionate and individualized care for each patient Our Primary Hospitals The General Hospital for Chinese Peoples Armed Police Forces (Wujing Hospital) Beijing Friendship Hospital, Capital Medical Unversity
Dr. Shewen Luo (Sherman) MD.PHD, the People's Armed Police General Hospital (Wujing Hosptial), Director of International Cancer Treatment Center The Chairman of international medical department at WJGH. His field is combined to Traditional Chinese medicine and Western medicine.He is the secretary-general of senile disease branch at association of traditional Chinese medicine in China.The deputy director of traditional Chinese medicine institution at gerontology association in China; The executive member of the council at pulmonary disease committee in the world association of Chinese medicine. He is also member of Beijing Chinese medicine academic society and gerontology committee in the Chinese people’s armed police force.He has experience at diabetes, cerebrovascular and cardiovascular disease; chronic cough, asthma syndrome, thirst, constipation and incurable insomnia and specializes in traditional Chinese medicine cancer treatment. As well as, patients psychological counseling.

Dr. Danmei Zhang (May) MD PHD the People's Armed Police General Hospital (Wujin Hosptial) The Chief Physician at WJ International Medical Center. Graduated from Second Medical College of PLA in Shanghai, China. As a postdoctoral fellow, studied at Baylor College of Medicine in Houston, USA; at Louisiana University Medical Center in New Orleans USA; at New York hospital, it belongs to Weill Medical College, Cornell University in New York, USA.Specializes in geriatrics, respiratory diseases, lung cancer, internal medicine, health management, fiber bronchoscopic diagnosis and treatment, and proficient in molecular biological therapy. Technology. She was a chairman of respiratory department and #2 VIP department. She was also serving in Cardiology Department and Emergency Department. Now, she is a senile disease physician, to get in touch with general medicine problem.

Prof. Xiao WenHua, The 304 Hosptial, Director of Oncology Graduated from one of the most famous HuaXi Southwest Medical University. Also, engaged with the Third Military Hospital Medical University for clinical research in cancer. Professor Xiao, is also the Director of the First affiliated hospital of Chinese PLA General Hospital Oncology. Cancer members of the Special Committee of the Army; Member of Anti-cancer Association in Beijing; Aged cancer of Chinese anti-cancer Association Executive Committee members of the IPCC. With the best knowledge of common tumors, such as lung, liver, breast, gastrointestinal, renal cancer. Dr. Xiao, also has extensive experiences with stem cell transplantation for malignant tumors, cancer chemotherapy drug sensitivity test of individual guidance, cancer vaccines and immunotherapy of dendritic cell tumor and tumor-targeting therapy.

Prof. Cui Zheng The Chief Scientist of LIFT cancer treatment, the chief scientist of Wake Forest University and Pathological cancer Cui Zheng MD PhD,also a biochemist currently serving as an Associate Professor of Pathology (Tumor Biology) at Wake Forest University. As an oncologist and a cancer researcher Cui has proposed the unique idea that certain individuals (estimated at 10% to 15% of the human population) naturally produce a special kind of white blood cell that contains an inherent resistance to cancer. This idea is extremely controversial within the cancer biology community. These white blood cells, in Cui's view, could potentially be extracted from donors and given to cancer victims, thus endowing them with cancer resistance. Cui's research seems to indicate that the resistance includes many types of cancer. Cui's research is based on experiments on mice. These experiments resulted in Cui being able to cure cancer in several otherwise terminally sick mice. Cui is proposing eventual experimentation of the technique on human subjects.

Hao Jingsheng, PhD --- Technicial Director, Hebei Willcom Stem Cell Life Science & Technology Labortory Healthcare Dr. Hao received his doctoral (Ph.D.) degree from the First Military Medical University. He dedicated to clinical and cancer immunotherapy studies & hematology research. He is now serving as the Technicial Director, after worked for several Beijing well-known medical and disease research institutions with great contributions.

He Ren PHD --- Senior Medical Oncology Engineer, Hebei Willcom Stem Cell Life Science & Technology Labortory Dr Ren is specializing in stem cell biology, tumor immunology as well as stem cell therapy-related technical processes involved with umbilical cord mesenchymal stem cells in class I - drug research and development, chaired and participated in 3 different projects from National Natural Science Foundation of China , and 863 other biology study projects Received his MD from 2007 Beijing Union Medical College, after graduation he has been engaged in the research and development of stem cell product commercialization and clinical transformation, presided over and participated in a number of stem cells to treat blood diseases and autoimmune diseases clinical research . He received Tianjin and the Binhai New Area Science and Technology Progress Award; also a chairmember of National Stem Cell Engineering Research Center for Academic Department. Representative works 1. Ren H, Zhao H, Wang T, et.al Leptin enhances in vitro secretion of IgG antiplatelet antibodies by splenocytes and peripheral blood mononuclear cells from patients with chronic idiopathic thrombocytopenic purpura. Clin Immunol. 2006; 120 (2): 205 - 11 . 2. Han ZB, Ren H (Co-first author), Zhao H, et.al Hypoxia-inducible factor (HIF) -1 alpha directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF). Carcinogenesis. 2008; 29 (10) :1853-61.

Our Vision:

Cancer is painful but the treatments shouldn’t be. For advanced-stage cancer patients, the cutting-edge therapies available in China offer a better hope for a prolonged life. The benefits of our biomedical method include a higher rate of cancer survivorship, a lower percentage of cancer recurrence and metastasis, minimal pain, minimal side effects, and a higher quality of life.

Cancer can be treated by surgery, chemotherapy, radiation therapy, immunotherapy, monoclonal antibody therapy or other methods. The choice of therapy depends upon the location and grade of the tumor and the stage of the disease, as well as the general state of the patient (performance status). A number of experimental cancer treatments are also under development.

Complete removal of the cancer without damage to the rest of the body is the goal of treatment. Sometimes this can be accomplished by surgery, but the propensity of cancers to invade adjacent tissue or to spread to distant sites by microscopic metastasis often limits its effectiveness. The effectiveness of chemotherapy is often limited by toxicity to other tissues in the body. Radiation can also cause damage to normal tissue.

Many of our treatments are not fully available in other developed countries, offering China a unique leading advantage. We work with hospitals that provide a systematic combination of the following treatments to combat cancer

Our Mission:

The Cancer Bio Master offers a unique concept in the diagnosis and biotreatment of cancer in Beijing according to the international standard of oncological care. Our goal is to provide the most up-to-date treatments to maximize the chance for cure and effective long-term control of oncological disorders. We also provide services for consultation, screening and early detection of cancer. We have a multidisciplinary team of physicians, nurses and supporting personnel, who are committed to provide compassionate and individualized care for each patient

Our Primary Hospitals

The General Hospital for Chinese Peoples Armed Police Forces (Wujing Hospital)

Beijing Friendship Hospital, Capital Medical Unversity

Dr. Shewen Luo (Sherman) MD.PHD, the People's Armed Police General Hospital (Wujing Hosptial), Director of International Cancer Treatment Center

The Chairman of international medical department at WJGH. His field is combined to Traditional Chinese medicine and Western medicine.He is the secretary-general of senile disease branch at association of traditional Chinese medicine in China.The deputy director of traditional Chinese medicine institution at gerontology association in China; The executive member of the council at pulmonary disease committee in the world association of Chinese medicine. He is also member of Beijing Chinese medicine academic society and gerontology committee in the Chinese people’s armed police force.He has experience at diabetes, cerebrovascular and cardiovascular disease; chronic cough, asthma syndrome, thirst, constipation and incurable insomnia and specializes in traditional Chinese medicine cancer treatment. As well as, patients psychological counseling.

Dr. Danmei Zhang (May) MD PHD the People's Armed Police General Hospital (Wujin Hosptial)

The Chief Physician at WJ International Medical Center. Graduated from Second Medical College of PLA in Shanghai, China. As a postdoctoral fellow, studied at Baylor College of Medicine in Houston, USA; at Louisiana University Medical Center in New Orleans USA; at New York hospital, it belongs to Weill Medical College, Cornell University in New York, USA.Specializes in geriatrics, respiratory diseases, lung cancer, internal medicine, health management, fiber bronchoscopic diagnosis and treatment, and proficient in molecular biological therapy. Technology. She was a chairman of respiratory department and #2 VIP department. She was also serving in Cardiology Department and Emergency Department. Now, she is a senile disease physician, to get in touch with general medicine problem.

Prof. Xiao WenHua, The 304 Hosptial, Director of Oncology

Graduated from one of the most famous HuaXi Southwest Medical University. Also, engaged with the Third Military Hospital Medical University for clinical research in cancer. Professor Xiao, is also the Director of the First affiliated hospital of Chinese PLA General Hospital Oncology. Cancer members of the Special Committee of the Army; Member of Anti-cancer Association in Beijing; Aged cancer of Chinese anti-cancer Association Executive Committee members of the IPCC. With the best knowledge of common tumors, such as lung, liver, breast, gastrointestinal, renal cancer. Dr. Xiao, also has extensive experiences with stem cell transplantation for malignant tumors, cancer chemotherapy drug sensitivity test of individual guidance, cancer vaccines and immunotherapy of dendritic cell tumor and tumor-targeting therapy.

Prof. Cui Zheng The Chief Scientist of LIFT cancer treatment, the chief scientist of Wake Forest University and Pathological cancer

Cui Zheng MD PhD,also a biochemist currently serving as an Associate Professor of Pathology (Tumor Biology) at Wake Forest University. As an oncologist and a cancer researcher Cui has proposed the unique idea that certain individuals (estimated at 10% to 15% of the human population) naturally produce a special kind of white blood cell that contains an inherent resistance to cancer. This idea is extremely controversial within the cancer biology community. These white blood cells, in Cui's view, could potentially be extracted from donors and given to cancer victims, thus endowing them with cancer resistance. Cui's research seems to indicate that the resistance includes many types of cancer. Cui's research is based on experiments on mice. These experiments resulted in Cui being able to cure cancer in several otherwise terminally sick mice. Cui is proposing eventual experimentation of the technique on human subjects.

Hao Jingsheng, PhD --- Technicial Director, Hebei Willcom Stem Cell Life Science & Technology Labortory Healthcare

Dr. Hao received his doctoral (Ph.D.) degree from the First Military Medical University. He dedicated to clinical and cancer immunotherapy studies & hematology research. He is now serving as the Technicial Director, after worked for several Beijing well-known medical and disease research institutions with great contributions.

He Ren PHD --- Senior Medical Oncology Engineer, Hebei Willcom Stem Cell Life Science & Technology Labortory

Dr Ren is specializing in stem cell biology, tumor immunology as well as stem cell therapy-related technical processes involved with umbilical cord mesenchymal stem cells in class I - drug research and development, chaired and participated in 3 different projects from National Natural Science Foundation of China , and 863 other biology study projects

Received his MD from 2007 Beijing Union Medical College, after graduation he has been engaged in the research and development of stem cell product commercialization and clinical transformation, presided over and participated in a number of stem cells to treat blood diseases and autoimmune diseases clinical research .

He received Tianjin and the Binhai New Area Science and Technology Progress Award; also a chairmember of National Stem Cell Engineering Research Center for Academic Department.

Representative works

1. Ren H, Zhao H, Wang T, et.al Leptin enhances in vitro secretion of IgG antiplatelet antibodies by splenocytes and peripheral blood mononuclear cells from patients with chronic idiopathic thrombocytopenic purpura. Clin Immunol. 2006; 120 (2): 205 - 11 .

2. Han ZB, Ren H (Co-first author), Zhao H, et.al Hypoxia-inducible factor (HIF) -1 alpha directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF). Carcinogenesis. 2008; 29 (10) :1853-61.